Time
|
Event
|
|
SUNDAY, APRIL 18, 2010
The Sunday program is dedicated to workshops and educational sessions.
There is a fee for these sessions. You do not have to be a registered
delegate to attend a workshop; however advance sign-up is required. Space is
limited. All workshops will be conducted in English.
|
|
8:00 am – 7:00 pm
|
Registration Desk Open
|
|
8:00 am – 9:00 am
|
Morning Workshop Registration
|
|
9:00 am – 12:00 pm
|
Workshop
|
| |
Workshop
1 – Advanced PubMed Searching
- Mr.
Emmanuel Nkansah, Canadian Agency for Drugs and Technologies in Health
- Ms. Hayley Fitzsimmons, Canadian Agency for Drugs and Technologies in Health
|
|
Workshop 2: Value
of Information: Vision of Ingenuity or Venture
of Icarus?
- Dr. Matthias Bischof, Programs for Assessment of Technology in
Health (PATH) Research Institute & McMaster University
- Prof. Gord Blackhouse, Programs for Assessment of Technology in
Health (PATH) Research Institute & McMaster University
- Prof. Ron Goeree, Programs
for Assessment of Technology in Health (PATH) Research Institute
& McMaster
University
- Dr. Feng Xie, Programs for Assessment of Technology in Health
(PATH) Research Institute & McMaster
University
|
|
|
Workshop 3: Patient-Reported Outcomes Research Supporting Drug
Approvals and Reimbursement
- Dr.
Heather-Jane Au, University
of Alberta and
Cross Cancer Institute
- Dr.
John Powers, George Washington University
& University of Maryland School of Medicine
- Ms.
Kathy Beusterien, Oxford
Outcomes
- Mr.
Phil la Fleur, Canadian Agency for Drugs and Technologies in Health
- Dr.
Adrian Levy, Dalhousie University & Oxford Outcomes
|
|
Workshop 4 – Audit and Feedback
- Dr.
Jeremy Grimshaw, University
of Ottawa
- Dr.
Penny Davis, University
of Saskatchewan
|
|
12:00 pm – 1:00 pm
|
Afternoon Workshop Registration
|
|
1:00 pm – 4:00 pm
Workshops
|
Workshop
|
| |
Workshop
5 – Fast and Furious: Do Rapid Reviews Deliver the Goods for Health Care
Decision Makers?
- Mr.
Don Husereau, Canadian Agency for Drugs and Technologies in Health
- Mr.
Ken Bond, Alberta
Research Centre For Health Evidence
- Ms. Anne Tweed, Nova Scotia Department of Health
- Ms. Suzanne Jones, New Brunswick Department of
Health
- Mr. David Moher, University of Ottawa
- Ms. Catherine
Gaulton, Capital Health
|
|
Workshop
6 – Live Demonstration of the Web-enabled Cancer risk Management Model
to Evaluate Cancer Control Strategies
- Mr.
William Flanagan, Statistics Canada
- Ms.
Janey Shin, Canadian Partnership Against Cancer
- Ms.
Gina Lockwood, Canadian Partnership Against Cancer
|
|
Workshop
7 – Assessing Risk of Bias in Randomized and Non-Randomized Designs – The Cochrane
EPOC approach
- Mr.
Alain Mayhew, Cochrane Effective Practice and Organisation of
Care Group
- Ms.
Julia Worswick, Cochrane Effective Practice and Organisation of Care
Group
- Ms.
Rachel Bennett, Cochrane Effective Practice and Organisation of
Care Group
|
|
Workshop 8: Indirect Comparisons
- Dr. George Wells, University of Ottawa Heart Institute
- Mr. Vijay Shukla, Canadian Agency for Drugs and
Technologies in Health
- Mr. Chris Cameron, Canadian Agency for Drugs and
Technologies in Health
|
|
5:00 pm – 7:00 pm
|
Welcome Reception and Scientific
Poster Exhibition
|
|
MONDAY, APRIL 19, 2010
|
|
7:30 am – 5:00 pm
|
Registration Desk Open
|
|
7:30 am – 8:30 am
|
Breakfast
|
|
8:30 am – 9:00 am
|
Official Opening
|
|
9:00 am – 10:30 am
|
PLENARY
|
| |
Opening Plenary
DELIVERING VALUE FOR MONEY IN HEALTH CARE FOR CANADIANS
The Opening Plenary will outline the issues and challenges associated with
delivering value for money in health care for Canadians and explore the
crucial role played by health technology assessment, including drug reviews
and optimal usage recommendations in helping policy-makers, planners and
health care professionals harness the benefits of technology while getting
the best value for money.
|
|
10:30 am – 11:00 am
|
Refreshment Break
|
|
11:00 am – 12:30 pm
|
CONCURRENT SESSIONS
|
| |
Concurrent Session 1: Orals - Policy Challenges
An evidence-based framework for evaluating new fee requests in Nova Scotia –
successes and challenges in the first year
- Presentation
Dr.
Anne Tweed, Nova Scotia Department of Health
Pharmacogenetics and the Evaluation Challenges associated with
Personalized Medicine
- Presentation
Ms. Catherine Street, Faculty
Of Medicine, Memorial
University of Newfoundland
Ms.
Astrid Perrot-Daley, Population Therapeutics Research Group -
Memorial University
of Newfoundland
A discrete choice experiment investigating preferences for funding drugs
used to treat orphan diseases
|
Concurrent Session 2: Orals - Clinical Challenges
Use of SSRI antidepressants in pregnancy: is there evidence of benefit?
- Presentation
Dr.
Barbara Mintzes, University
of British Columbia
Evaluating Change in National Breast Screening Performance Indicators
Following the Implementation of Full Field Digital mammography (FFDM)
Economic evaluation of dose-response resistance training in older women: a
cost-effectiveness and cost utility analysis
|
|
Concurrent Session 3: Orals – International Comparisons
Comparative Effectiveness: Evolving the Discussion in Canada
- Presentation
Ms.
Lisa Purdy, Deloitte
- Ms.
Elisabeth Peloso, Deloitte
Does Comparative Effectiveness Research Have Lessons to Learn from HTA?
Comparative Study of Canada’s CDR Process and Other HTA Processes
|
|
Concurrent Session 4: Orals – Perspectives on Value for Money
Identifying Best Buys in Health Care for Canadian Patients and Consumers: Where is the Value for the Money?
- Presentation
Dr.
Katharina Kovacs Burns, Best Medicines Coalition
Health Technology Assessment: Challenges faced by the Medical Device
Industry
Criteria and Factors Influencing Take up of Health Technology Assessments
(HTAs) by Public Drug Plans to Inform Decision Making on the Public
Reimbursement of Drugs
|
|
Concurrent Session 5: Orals – From Evidence to Practice
Using Evidence for Jurisdictional Policy Impact: Bupivacaine
- Presentation
Ms.
Brendalynn Ens, Canadian Agency for Drugs and Technologies in Health
A Provincial Structure that Translates Evidence Into Best Practice
- Presentation
Ms.
Dawn Frail, Nova Scotia Department of Health
- Ms.
Lisa Farrell, Canadian Agency for Drugs and Technologies in
Health
Supporting the Knowledge to Action Process: Utilizing the Knowledge
Exchange-Decision Support (KE-DS) Toolkit with Cancer Survivorship
Initiatives
- Presentation
Dr.
Arminée Kazanjian, University
Of British Columbia
|
|
12:30 pm – 1:30 pm
|
Lunch
|
| |
CONCURRENT SESSIONS
|
|
1:30 pm – 3:00 pm
|
Concurrent Session 6: Panel – Evaluation of New Drugs in Canada: Human
Resource Challenges
- Presentation
Dr.
Stuart MacLeod, Child & Family Research Institute
Dr.
Judith Soon, Community Pharmacist Research Network
- Presentation
Dr.
Ingrid Sketris, Dalhousie
University
|
|
Concurrent Session 7: Panel – Harmonizing Proof of Concept with
Proof of Value
- Presentation
Dr. Robert Peterson, Canadian Institutes of Health Research
- Presentation
Dr. Judith Glennie,
Janssen-Ortho Inc.
- Presentation
Mr. David K. Lee, Health Canada
- Presentation
Dr. Laurie Mallery, Dalhousie
University
- Presentation
Judy McPhee A. Director, Pharmaceutical Service Nova Scotia Depart. of Health
|
|
Concurrent Session 8: Panel – Health Professionals, Decision Makers and
Optimal Prescribing: Toward an Effective Strategy for all
- Presentation
Dr. Samuel Shortt,
Canadian Medical Association
- Ms. Barb Shea, Canadian Agency for Drugs and
Technologies in Health
- Dr. Mike Allen, Dalhousie
University
- Dr.
Neil MacKinnon, Dalhousie
University
|
|
Concurrent Session 9: Panel – Health Care Technology and Infection
Control: Impact on Practice and Policy
- Presentation
Ms.
Julie Polisena, Canadian Agency for Drugs and Technologies in Health
- Presentation
Dr.
Kevin Forward, QEII Health Sciences Centre
- Presentation
Ms.
Patsy Rawding, Nova Scotia,
Department of Health
- Presentation
Dr. Ian Davis,
Queen Elizabeth II Health Sciences
Centre
|
|
Concurrent Session 10: Panel – Advancing the Science: Methodological
Challenges in HTA
- Presentation
Mr. Chris Cameron, Canadian Agency for Drugs and
Technologies in Health
- Presentation
Ms. Karen Lee, Canadian Agency for Drugs and
Technologies in Health
- Presentation
Lisa Dolovich, Associate Professor, Department of Family Medicine, McMaster University
|
|
3:00 pm – 3:30 pm
|
Refreshment Break
|
| |
CONCURRENT SESSIONS
|
|
3:30 pm – 5:00 pm
|
Concurrent Session 11: Panel - Methodological Innovations and Practical Considerations Pertaining to the Creation of Risk-Sharing Arrangements for Health Products in Canada
|
|
Concurrent Session 12: Orals – Changing Behaviour
From Kitchen to Dining Room Table: Taking a COMPUS Report and Making it
Palatable
- Presentation
Mr.
Loren Regier, RxFiles Academic Detailing Service
A Systematic Review of Interventions that Optimize Medication Prescribing
and Use in Canada
Changing Professional Behaviour: An updated Overview of Systematic Reviews
- Presentation
Mr.
Alain Mayhew, Cochrane Effective Practice and Organisation of Care Group
The KATIE Program
- Presentation
Mr. Glenn
Rodrigues, Dalhousie
University
- Dr.
Michael Allen, Dalhousie
University
|
|
Concurrent Session 13: Orals – Ethics
Assessing Ethical Issues within HTA Practices: The Case of Deep
Brain Stimulation (DBS)
Improving Ethical Analysis in HTA
- Presentation
Mr.
Kenneth Bond, Alberta
Research Centre for Health Evidence
- Ms.
Katherine Duthie, University
of Alberta
Social Values and Health Technology Policy Analysis: The Role for
Qualitative Social Science and Humanities Research Evidence
|
|
Concurrent Session 14: Orals – Hot Topics in Policy Circles
Health Outcomes of Care: An Idea Whose Time Has Come
- Presentation
Dr.
Claudia Sanmartin, Statistics Canada
- Ms.
Kira Leeb, Canadian Institute for Health Information
Serious Adverse Events to Determine Benefit and Harm of Drug Therapy: An
Example using Daptomycin for Systemic Infections
- Presentation
Dr.
Aaron Tejani, Therapeutics Initiative (UBC) / Fraser Health Pharmacy
Services
Drug Safety and Effectiveness Network
- Presentation
Dr.
Robert Peterson, Canadian Institutes of Health Research
Addressing Research and Development Needs with a National Centre for
Health Economics, Services, Policy and Ethics
- Presentation
Dr.
Jeffrey Hoch, Canadian Centre for Applied Research in Cancer
Control
|
|
Concurrent Session 15: Orals – Value for Money – Cost Effectiveness
Guidelines
The Paradox of the Laupacis Parallax
Discounting and decision making in the economic evaluation of health care
technologies
- Presentation
Mr.
Mike Paulden, Toronto
Health Economics and Technology Assessment Collaborative
A Canadian valuation of the EQ-5D health states
- Presentation
Mr.
Nick Bansback, Centre For Health Evaluation And Outcome Sciences
|
|
5:30 pm – 9:00 pm
|
Symposium Dinner – Pier 21
Cocktails from 5:30 – 6:30.
Dinner and evening program begins promptly at 6:30 pm
Shuttle buses will leave
from the front entrance of the Halifax Marriott Hotel
|
|
TUESDAY, APRIL 20, 2010
|
|
7:30 am - 2:45 pm
|
Registration Desk Open
|
|
7:30 am – 8:30 am
|
Buffet Breakfast
|
|
8:30 a.m. – 10:00 am
|
PLENARY
|
| |
Plenary Session
VALUE FOR MONEY: OBSOLESCENCE OF HEALTH TECHNOLOGIES / DISINVESTMENT
Disinvestment – withdrawing health resources from existing healthcare
practices, procedures, technologies, or drugs that are deemed to deliver
little or no health gain for their cost – supports quality of care and
efficient health resource allocation. Panelists will explore the
opportunities, practice and issues associated with disinvestment in Canada and
elsewhere.
|
|
10:00 am – 10:30 am
|
Refreshment Break
|
|
10:30 am – 12:00 pm
|
CONCURRENT SESSIONS
|
| |
Concurrent Session 16: Panel – Best Brains Exchange: A Rapid, Relevant
Research Response to Health Ministry Priorities
- Mr.
Chris McCutcheon, Canadian Institutes Of Health Research
- Ms.
Meghan McMahon, Institute
of Health Services
and Policy Research
|
|
Concurrent Session 17: Panel – Considerations
for the Use of Subsequent-Entry Biologics in Canada
- Dr. Philip Schwab,
BIOTECanada
- Presentation
Dr. Stuart MacLeod, University
of British Columbia, Cameron Institute
- Presentation
Dr. Agnes Klein, Health Canada
- Presentation
Dr. Alan West,
Gowling, Lafleur, Henderson, Toronto
- Presentation
Mr. Michael Guirguis, Alberta Health Services
(invited)
|
|
Concurrent Session 18: Panel – Value versus Values: It’s All About the
Evidence Unless it’s Cheaper
|
|
Concurrent Session 19: Panel – From Evidence to Practice: Changing the
Approach to Self-Management of Diabetes
- Ms.
Barb Shea, Canadian Agency for Drugs and Technologies in Health
- Presentation
Mr.
Denis
Bélanger, Canadian Agency for Drugs and Technologies in Health
- Lisa Dolovich, Department of Family Medicine, McMaster University
- Rockie Palmer, Federal Healthcare Partnership
Jonathan Fowles, Acadia University
|
|
Concurrent Session 20: Orals – Impacting Policy
- Presentation, The Ontario Drug Policy Research Network: Generating Evidence to Inform Policy
Ms.Tara
Gomes, Ontario
Drug Policy Research Network
- CADTH’s
Rapid Response Program and the Policy Forum: A Partnership to Promote
Evidence-Informed Decisions About PET Scanning in Oncology
- Presentation
Dr.
Lesley Dunfield, Canadian Agency for
Drugs and Technologies in Health
- Ms.
Jocelyn Chisamore, Canadian Agency
for Drugs and Technologies in Health
- Synthesizing
existing research evidence to support local health decision making:
Lessons
learned in NL
- Presentation
Dr. Stephen Bornstein,
Newfoundland and Labrador
Centre For Applied Health Research
- Knowledge
Exchange: A Strategy for Success
- Presentation
Ms. Jeannette Smith, Canadian Agency for Drugs and
Technologies in Health
- Ms. Brendalynn Ens, Canadian Agency for Drugs and
Technologies in Health
|
|
12:00 pm – 1:00 pm
|
Awards Luncheon
|
|
1:00 pm – 2:30 pm
|
PLENARY
|
| |
Closing Plenary
VALUE FOR MONEY: THE EVOLVING ROLE OF HTA
Building on the opening plenary and the Symposium as a whole, this session
will feature a free-wheeling discussion about what else can and should be
done to ensure value for money in health care for Canadians, with a
particular emphasis on the role of health technology assessment, where Canada
is already best and where we can improve.
|
|
2:30 pm – 2:45 pm
|
Official Closing
|
